NDC 14403-3400-02 - Liraglutide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 14403-3400
- Requested NDC
- 14403-3400-02
- Package NDCs from labels
- 14403-3400-1, 14403-3400-2, 14403-3400-3, 14403-3400-02
- Manufacturer
- Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
- Effective date
- 2024-12-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Liraglutide - Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 2024-12-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Liraglutide - Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 2024-12-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Liraglutide - Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 2024-06-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 14403-3400-1 | Liraglutide | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 4 | |
| 14403-3400-2 | Liraglutide | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 4 | |
| 14403-3400-1 | Liraglutide | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 3 | |
| 14403-3400-3 | Liraglutide | 3 in 1 CARTON | INJECTION, SOLUTION | 3 | 3 | |
| 14403-3400-1 | Liraglutide | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 14403-3400 | LIRAGLUTIDE INJECTION, SOLUTION [HYBIO PHARMACEUTICAL CO., LTD. (PINGSHAN FACTORY)] | 4 | Current NDC, 2 package rows | 20241225_1a372465-d56b-2b80-e063-6394a90a3304.zip |
| 14403-3400 | LIRAGLUTIDE INJECTION, SOLUTION [HYBIO PHARMACEUTICAL CO., LTD. (PINGSHAN FACTORY)] | 3 | Current NDC, 2 package rows | 20241225_1a36f43f-d734-97cc-e063-6294a90ae0da.zip |
| 14403-3400 | LIRAGLUTIDE INJECTION, SOLUTION [HYBIO PHARMACEUTICAL CO., LTD. (PINGSHAN FACTORY)] | 1 | Current NDC, 1 package rows | 20241224_1a36b801-41e2-2eed-e063-6294a90a6f27.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Liraglutide | LIRAGLUTIDE | Meitheal Pharmaceuticals Inc. | 0efc3a89-211a-4496-baab-e8265e07de2b | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| Liraglutide | LIRAGLUTIDE | NorthStar Rx LLC | 4253be3b-bda6-4efd-8118-9c9538168a88 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| liraglutide | LIRAGLUTIDE | Cipla USA Inc. | 22c86976-9657-4dd0-8fff-0c3f3f08357c | 2026-06-18 | Boxed warning, Warnings, Adverse reactions | 839I73S42A |
| Liraglutide | LIRAGLUTIDE | Hikma Pharmaceuticals USA Inc. | 2100ec49-57b2-4330-ab5f-057ce9b7e4d0 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | ANDA215503 897122 839I73S42A |
| liraglutide | LIRAGLUTIDE | Orbicular Pharmaceutical Technologies Private Limited | d2bfc30a-8392-4255-a4d8-fa0b8d1659b2 | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 839I73S42A |
| LIRAGLUTIDE | LIRAGLUTIDE | Orbicular Pharmaceutical Technologies Private Limited | bb66a46c-9019-4a98-8e5d-581109facfba | 2026-03-12 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| Liraglutide | LIRAGLUTIDE | Teva Pharmaceuticals, Inc. | 625ac780-70a9-41e4-a892-bcba0f803f1c | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | 839I73S42A |
| Saxenda | LIRAGLUTIDE | Novo Nordisk Pharmaceutical Industries, LP | 3946d389-0926-4f77-a708-0acb8153b143 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 839I73S42A |
| Liraglutide | LIRAGLUTIDE | Teva Pharmaceuticals USA, Inc. | 14bf9812-14ee-46ce-93b1-686e4906cbbc | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| LIRAGLUTIDE | LIRAGLUTIDE | Cipla USA Inc. | 8fe557ae-4ff0-47a2-8ec3-37bb0fbdcc64 | 2026-01-12 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| Liraglutide | LIRAGLUTIDE | Lupin Pharmaceuticals, Inc. | 0450d8a2-a88e-4849-9788-ed4f5246f223 | 2025-11-13 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| Liraglutide | LIRAGLUTIDE | Biocon Pharma Inc. | 0b898330-eca1-f60a-71d2-b91716e336ed | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 839I73S42A |
| Victoza | LIRAGLUTIDE | Novo Nordisk | 5a9ef4ea-c76a-4d34-a604-27c5b505f5a4 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| Xultophy 100/3.6 | INSULIN DEGLUDEC AND LIRAGLUTIDE | Novo Nordisk | 21335fe4-d395-4501-ac2a-2f20d7520da9 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 839I73S42A |
| Liraglutide | LIRAGLUTIDE | Biocon Pharma Inc. | cb032379-043b-443c-d552-b5d25f27f3c4 | 2025-10-10 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| Liraglutide | LIRAGLUTIDE | A-S Medication Solutions | 0ba917f7-b974-4364-a745-7494ecae3e73 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 897122 839I73S42A |
| Liraglutide | LIRAGLUTIDE | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 1a372465-d56b-2b80-e063-6394a90a3304 | 2024-12-03 | Warnings, Adverse reactions | ANDA215503 14403-3400-2 14403-3400-1 14403-3400 14403340002 897122 2854c47e-c069-07d7-e063-6394a90a50eb 1a372465-d56b-2b80-e063-6394a90a3304 839I73S42A |
| Liraglutide | LIRAGLUTIDE | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 1a36f43f-d734-97cc-e063-6294a90ae0da | 2024-12-02 | Warnings, Adverse reactions | ANDA215503 14403-3400-3 14403-3400-1 14403-3400 897122 28439e3c-4761-7d3d-e063-6394a90a571d 1a36f43f-d734-97cc-e063-6294a90ae0da 839I73S42A |
| Liraglutide | LIRAGLUTIDE | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 1a36b801-41e2-2eed-e063-6294a90a6f27 | 2024-06-05 | Warnings, Adverse reactions | ANDA215503 14403-3400-1 14403-3400 897122 1a36a385-111a-f5a9-e063-6294a90a29a7 1a36b801-41e2-2eed-e063-6294a90a6f27 839I73S42A |
| Saxenda | LIRAGLUTIDE | A-S Medication Solutions | 7b11f6ac-4c27-4748-9e65-22d4cf3adfb4 | 2024-01-26 | Boxed warning, Warnings, Adverse reactions | 839I73S42A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.